Address
Contact
Tel: 0341 355 238 511 Fax: +49 341 1246978 leipzig@selfdiagnostics.com www.selfdiagnostics.euOffer
As one of Europe‘s most ambitious healthcare ventures, SelfDiagnostics holds a unique Nucleic Acid detection based technology for medical devices that helps detect diseases and provides diagnosis at home. Our proprietary NINAAT (Non-Instrument Nucleic Acid Amplification Technology) based molecular diagnostics platform will be applicable for human diagnostic tests on infectious and genetic diseases and can be easily adaptable in other fields of application in the future. For the first time a fully disposable test for home use will deliver results within 30 minutes that matches the sensitivity and specificity close to gold standard techniques. Our POC (Point of Care) NINAAT diagnostic platform provides a disruptive technology challenging current test methods in healthcare system as well as in the fields in which robust detection of nucleic acids is an advantage.
As a first application of our NINAAT, a first human healthcare test product under the brand name “InTime” is scheduled for launch in 2018. It detects two of the most common sexually transmitted pathogens – Chlamydia trachomatis (CT) and Neisseria gonorrhea (NG) from urine. Further fields of application - beyond healthcare - include pets and livestock veterinary, food safety testing and the detection of biological threats at the site of contamination will be introduced in coming years.